Biotechnology Analysis & Statistics, December 2014 (p40)

24/7 Customer Support

Talk to Louis

+44 20 3286 0679

Publishers

All regions

1171-1200 of about 4 300 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • € 8 796
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical
  • Countries : World
Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity ...

  • Industries : Pharmaceutical, Pathology
Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology, Biotechnology
  • Countries : World
Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World
Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical, Biopharmaceutical
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • € 3 996
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Freedonia Focus on Biocompatible Metals: United States

Freedonia Focus on Biocompatible Metals: United States

  • € 480
  • Industry report
  • December 2014
  • by Freedonia Focus

This report forecasts US biocompatible metal demand in US dollars at the manufacturers’ level to 2018. Total demand is segmented by material in terms of precious metals, stainless steel, titanium, and ...

  • Industries : Biomaterial, Biomaterial
  • Countries : United States
Pollen Allergy - Pipeline Review, H2 2014

Pollen Allergy - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report ...

  • Industries : Drug and Medication, Biopharmaceutical, Research and Development, Pharmaceutical
  • Countries : Japan, World
Sinusitis - Pipeline Review, H2 2014

Sinusitis - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Sinusitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Sinusitis - Pipeline Review, H2 2014’, provides an overview of the Sinusitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug and Medication, Healthcare
  • Countries : United States, World
Bronchitis - Pipeline Review, H2 2014

Bronchitis - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Bronchitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Bronchitis - Pipeline Review, H2 2014’, provides an overview of the Bronchitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
Acute Spinal Cord Injury - Pipeline Review, H2 2014

Acute Spinal Cord Injury - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Spinal Cord Injury - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Spinal Cord Injury - Pipeline Review, H2 2014’, provides an overview of the Acute Spinal Cord Injury’s ...

  • Industries : Pathology
  • Countries : United States
Pemphigus - Pipeline Review, H2 2014

Pemphigus - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Pemphigus - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pemphigus - Pipeline Review, H2 2014’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
TiGenix NV - Product Pipeline Review - 2014

TiGenix NV - Product Pipeline Review - 2014

  • € 1 200
  • Industry report
  • December 2014
  • by Global Markets Direct

TiGenix NV - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TiGenix NV - Product Pipeline Review - 2014’, provides an overview of the TiGenix NV’s pharmaceutical research and ...

  • Industries : Research and Development, Biological Therapy
  • Countries : Spain, World
Oligodendroglioma - Pipeline Review, H2 2014

Oligodendroglioma - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Oligodendroglioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2014’, provides an overview of the Oligodendroglioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014

Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014" provides data on ...

  • Industries : Pharmaceutical, Drug and Medication, Biopharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014

Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Pneumococcal ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
Septicaemia Global Clinical Trials Review, H2, 2014

Septicaemia Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Septicaemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Septicaemia Global Clinical Trials Review, H2, 2014" provides data on the Septicaemia clinical trial scenario. ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Swine Influenza Global Clinical Trials Review, H2, 2014

Swine Influenza Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Swine Influenza Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Swine Influenza Global Clinical Trials Review, H2, 2014" provides data on the Swine Influenza clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Biopharmaceutical
  • Countries : World
CytomX Therapeutics, Inc. - Product Pipeline Review - 2014

CytomX Therapeutics, Inc. - Product Pipeline Review - 2014

  • € 1 200
  • Industry report
  • December 2014
  • by Global Markets Direct

CytomX Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘CytomX Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the CytomX Therapeutics, ...

  • Industries : Therapy, Research and Development, Biopharmaceutical, Pharmaceutical
  • Countries : World
Cervical Dysplasia - Pipeline Review, H2 2014

Cervical Dysplasia - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Cervical Dysplasia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cervical Dysplasia - Pipeline Review, H2 2014’, provides an overview of the Cervical Dysplasia’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, United States
Chlamydia Trachomatis Infections - Pipeline Review, H2 2014

Chlamydia Trachomatis Infections - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Chlamydia Trachomatis Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chlamydia Trachomatis Infections - Pipeline Review, H2 2014’, provides an overview of the Chlamydia Trachomatis ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : United States
Marburg Hemorrhagic Fever - Pipeline Review, H2 2014

Marburg Hemorrhagic Fever - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Marburg Hemorrhagic Fever - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Marburg Hemorrhagic Fever - Pipeline Review, H2 2014’, provides an overview of the Marburg Hemorrhagic Fever’s ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical, Drug and Medication
  • Countries : United States
Eastern Equine Encephalitis - Pipeline Review, H2 2014

Eastern Equine Encephalitis - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Eastern Equine Encephalitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Eastern Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Eastern Equine Encephalitis’s ...

  • Industries : Biopharmaceutical, Drug and Medication, Pharmaceutical, Pathology
  • Countries : World, Venezuela, United States
Yellow Fever Global Clinical Trials Review, H2, 2014

Yellow Fever Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Yellow Fever Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2014" provides data on the Yellow Fever clinical trial ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Therapy, Drug and Medication, Biopharmaceutical
  • Countries : World
Febrile Neutropenia Global Clinical Trials Review, H2, 2014

Febrile Neutropenia Global Clinical Trials Review, H2, 2014

  • € 2 000
  • Industry report
  • December 2014
  • by Global Data

Febrile Neutropenia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2014" provides data on the Febrile Neutropenia ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.